Sol-Gel Technologies (SLGL) Competitors $0.43 -0.01 (-2.54%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends SLGL vs. CELU, OMGA, PRLD, CASI, VTVT, MAAQ, KZR, XCUR, SNYR, and ACABShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Celularity (CELU), Omega Therapeutics (OMGA), Prelude Therapeutics (PRLD), CASI Pharmaceuticals (CASI), vTv Therapeutics (VTVT), Mana Capital Acquisition (MAAQ), Kezar Life Sciences (KZR), Exicure (XCUR), Synergy CHC Corp. (Uplisting) (SNYR), and Atlantic Coastal Acquisition Corp. II (ACAB). These companies are all part of the "pharmaceutical products" industry. Sol-Gel Technologies vs. Celularity Omega Therapeutics Prelude Therapeutics CASI Pharmaceuticals vTv Therapeutics Mana Capital Acquisition Kezar Life Sciences Exicure Synergy CHC Corp. (Uplisting) Atlantic Coastal Acquisition Corp. II Celularity (NASDAQ:CELU) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking. Does the media refer more to CELU or SLGL? In the previous week, Celularity's average media sentiment score of 0.00 equaled Sol-Gel Technologies'average media sentiment score. Company Overall Sentiment Celularity Neutral Sol-Gel Technologies Neutral Which has preferable earnings and valuation, CELU or SLGL? Sol-Gel Technologies has lower revenue, but higher earnings than Celularity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCelularity$48.20M1.06-$196.29MN/AN/ASol-Gel Technologies$11.71M1.02-$27.24M-$0.34-1.26 Do institutionals and insiders hold more shares of CELU or SLGL? 19.0% of Celularity shares are held by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are held by institutional investors. 22.1% of Celularity shares are held by insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in CELU or SLGL? Sol-Gel Technologies received 141 more outperform votes than Celularity when rated by MarketBeat users. Likewise, 63.40% of users gave Sol-Gel Technologies an outperform vote while only 42.11% of users gave Celularity an outperform vote. CompanyUnderperformOutperformCelularityOutperform Votes842.11% Underperform Votes1157.89% Sol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Do analysts prefer CELU or SLGL? Sol-Gel Technologies has a consensus price target of $5.00, indicating a potential upside of 1,065.50%. Given Sol-Gel Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sol-Gel Technologies is more favorable than Celularity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Celularity 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CELU or SLGL more profitable? Celularity has a net margin of -72.72% compared to Sol-Gel Technologies' net margin of -81.75%. Sol-Gel Technologies' return on equity of -27.17% beat Celularity's return on equity.Company Net Margins Return on Equity Return on Assets Celularity-72.72% -119.53% -25.40% Sol-Gel Technologies -81.75%-27.17%-22.49% Which has more risk and volatility, CELU or SLGL? Celularity has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. SummarySol-Gel Technologies beats Celularity on 11 of the 14 factors compared between the two stocks. Ad ProsperityPubCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.95M$6.57B$5.14B$9.08BDividend YieldN/A3.00%5.09%4.23%P/E Ratio-1.2610.5989.9717.18Price / Sales1.02195.801,116.21116.99Price / CashN/A57.1642.8937.86Price / Book0.265.094.784.78Net Income-$27.24M$151.83M$120.23M$225.60M7 Day Performance-10.53%-2.13%-1.92%-1.23%1 Month Performance-9.70%-3.10%11.49%3.36%1 Year Performance-66.48%11.54%30.57%16.60% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies2.4264 of 5 stars$0.43-2.5%$5.00+1,065.5%-65.7%$11.95M$11.71M-1.2650CELUCelularityN/A$2.29+3.2%N/A+36.9%$50.35M$48.20M0.00220OMGAOmega Therapeutics2.0272 of 5 stars$0.90-7.4%$9.20+925.0%-62.8%$49.70M$3.09M0.00120PRLDPrelude Therapeutics2.9348 of 5 stars$0.90+12.6%$4.00+344.2%-67.3%$49.55MN/A-0.52120News CoveragePositive NewsGap UpHigh Trading VolumeCASICASI Pharmaceuticals3.083 of 5 stars$3.18+2.3%$6.00+88.7%-59.2%$49.17M$22.06M-1.39180VTVTvTv Therapeutics2.0038 of 5 stars$15.30+1.8%$35.00+128.8%+70.4%$48.81M$2.02M-3.329Gap UpMAAQMana Capital AcquisitionN/A$5.99-23.2%N/A-53.4%$48.67MN/A0.001Gap UpHigh Trading VolumeKZRKezar Life Sciences3.7081 of 5 stars$6.62-1.9%$40.50+511.8%-25.0%$48.30M$7M-0.5060Analyst ForecastNews CoverageXCURExicure0.8904 of 5 stars$18.37+6.1%N/A+2,901.6%$47.95M$28.83M-9.2750News CoverageGap UpSNYRSynergy CHC Corp. (Uplisting)N/A$5.50+4.4%N/AN/A$47.85MN/A0.0040Positive NewsGap UpACABAtlantic Coastal Acquisition Corp. IIN/A$5.77-47.1%N/A-45.7%$47.14MN/A0.004High Trading Volume Related Companies and Tools Related Companies Celularity Alternatives Omega Therapeutics Alternatives Prelude Therapeutics Alternatives CASI Pharmaceuticals Alternatives vTv Therapeutics Alternatives Mana Capital Acquisition Alternatives Kezar Life Sciences Alternatives Exicure Alternatives Synergy CHC Corp. (Uplisting) Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SLGL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
